reported that the sensitivity of fecal DNA SDC2 methylation in patients with colorectal cancer was 90.0%, whereas that in patients with early‐stage CRC was 83.3% (stage I), with a specificity of 90.9%.[41] A multicenter clinical study by Wang JP et al. Here, SDC2 is linked to colorectal cancer.